Module- 5

Muscular and Skeletal Systems as scaffolds (architecture, mechanisms, bioengineering solutions for
muscular dystrophy and osteoporosis), scaffolds and tissue engineering, Bioprinting techniques and
materials, 3D printing of ear, bone and skin. 3D printed foods. Electrical tongue and electrical
nose in food science, DNA origami and Biocomputing, Bioimaging and Artificial Intelligence for
disease diagnosis. Self-healing Bio-concrete (based on bacillus spores, calcium lactate nutrients and
biomineralization processes) and Bioremediation and Biomining via microbial surface adsorption
(removal of heavy metals like Lead, Cadmium, Mercury, Arsenic).

Muscular Systems as Scaffolds

Muscles have the potential to be used as scaffolds for the regeneration of tissues due to
their inherent mechanical properties and ability to support cell growth and tissue formation. One
example of using muscular systems as scaffolds is in the treatment of damaged or diseased heart
tissue.
Researchers have developed methods for using muscle cells to create a functional, three-
dimensional scaffold that can support the growth of new heart tissue. In this approach, muscle
cells are harvested from the patient and then seeded onto a scaffold, such as a hydrogel or artificial
matrix. The scaffold provides a framework for the cells to grow and differentiate into new heart
tissue, which can help to repair the damaged or diseased tissue.
Another example is in the treatment of skeletal muscle injuries, such as those caused by
trauma or disease. In this case, muscle cells can be harvested and seeded onto a scaffold, which
can then be implanted into the damaged muscle to promote the growth of new, functional tissue.

Architecture
 Inside each skeletal muscle, muscle fibers are organized into bundles, called fascicles,
surrounded by a middle layer of connective tissue called the perimysium.
 This fascicular organization is common in muscles of the limbs; it allows the nervous
system to trigger a specific movement of a muscle by activating a subset of muscle fibers
within a fascicle of the muscle.
 Inside each fascicle, each muscle fiber is encased in a thin connective tissue layer of
collagen and reticular fibers called the endomysium.
 The endomysium surrounds the extracellular matrix of the cells and plays a role in
transferring force produced by the muscle fibers to the tendons.
 Inside the muscle fibers, there are tiny structures called myofibrils. Myofibrils are made
up of smaller units called sarcomeres, which are responsible for muscle contraction
 Sarcomeres contain thin (Actin) and thick filaments (Myosin) that work together to make
the muscle fibers contract.
  Each muscle fiber is surrounded by a protective layer called endomysium. Multiple
muscle fibers are grouped together into bundles called fascicles.
 Fascicles are surrounded by another layer of connective tissue called perimysium. All the
fascicles together make up the entire muscle, which is surrounded by a layer called
epimysium.
 The muscle also has a special membrane called the sarcolemma, which protects the
muscle fiber.
 Inside the muscle fiber, there are small tunnels called T-tubules that help transmit signals
for muscle contraction.
 Muscles work through the coordination of motor units, which consist of a motor neuron
and the muscle fibers it controls. This architecture allows muscles to generate force,
move our bodies, and perform various activities.

Mechanisms
The mechanism of how the muscular system can be used as a scaffold in regenerative
medicine involves the use of muscle cells and a scaffold to support the growth and regeneration
of new tissue.
The method of growing muscle tissue using hydrogel or artificial scaffold is explained
below:
  Harvesting of muscle cells: Muscle cells are typically obtained from the patient and then
isolated and expanded in culture.
 Seeding onto scaffold: The muscle cells are then seeded onto a scaffold, such as a
hydrogel or artificial matrix. The scaffold provides a framework for the cells to grow and
differentiate into new tissue.
 Cell differentiation and tissue formation: Once the cells are seeded onto the scaffold, they
undergo differentiation, in which they change into specific cell types, such as muscle
cells or heart cells. The cells also begin to organize and form new tissue, such as heart
tissue or skeletal muscle tissue.
 Implantation into patient: The scaffold and cells are then implanted into the patient to
promote the growth of new, functional tissue.
Muscle Cells as Scaffold
Muscle cells can be used as a scaffold for tissue generation by removing the living cells
from the muscle tissue, leaving behind the structure known as the extracellular matrix (ECM).
This decellularized muscle scaffold provides a framework that can guide and support the growth
of new tissues.
The Process
 Harvesting muscle tissue: A small sample of muscle tissue is taken, typically from a
donor or an animal model.
 Cell removal: The living cells within the muscle tissue are removed using a process
called decellularization. This involves treating the tissue with specific chemical solutions
or enzymes that break down and wash away the cellular components, while preserving
the ECM.
 ECM scaffold: The remaining ECM, which forms the structure of the muscle, is now a
scaffold. It consists of proteins, such as collagen and elastin, and other molecules that
provide support and signals for tissue growth.
 Seeding cells: The decellularized muscle scaffold is then seeded with desired cells. These
can be stem cells or specialized cells relevant to the type of tissue being regenerated. The
cells are introduced onto the scaffold, allowing them to attach and populate the structure.
 Tissue growth: Over time, the seeded cells proliferate and differentiate, meaning they
multiply and transform into specific cell types required for the desired tissue. The ECM
scaffold guides the cells' growth, providing physical support, and biochemical cues to
influence their behavior.
 Tissue integration: As the cells continue to grow, they populate the scaffold and form new
tissue. The new tissue integrates with the surrounding native tissue, gradually replacing
the decellularized scaffold with functional, regenerated tissue.
Bioengineering solutions for muscular dystrophy
Muscular dystrophy is a group of genetic disorders that result in progressive weakness and
degeneration of the skeletal muscles, which are responsible for movement. The disorders are
caused by mutations in genes that encode proteins needed for muscle function. The most common
type of muscular dystrophy is Duchenne muscular dystrophy, which typically affects young boys
and leads to severe disability by early adulthood. Other forms of the disease include Becker
muscular dystrophy, limb-girdle muscular dystrophy, and facioscapulohumeral dystrophy, among
others.
Bioengineering solutions for muscular dystrophy aim to improve the lives of individuals
affected by the disease by addressing the underlying genetic mutations and muscle weakness.
Some of the approaches being explored include:
 Gene therapy: This involves delivering a functional copy of the missing or mutated gene
to the affected muscle cells. The goal is to restore the production of the missing protein
and improve muscle function.
 Stem cell therapy: This involves using stem cells to replace the damaged muscle cells and
promote repair and regeneration of the muscle tissue. Stem cells can be taken from the
patient's own body (autologous stem cells) or from a donor (allogenic stem cells).
 Exoskeleton technology: This involves using wearable devices, such as robotic
exoskeletons, to support and enhance the movement of individuals with muscular
dystrophy. The devices use motors and sensors to mimic the movements of the wearer
and help improve mobility.
 Tissue engineering: This involves using a combination of materials, such as scaffolds and
growth factors, to promote the growth and repair of muscle tissue. The goal is to create
functional muscle tissue that can replace the damaged tissue in individuals with muscular
dystrophy.
These approaches are still in the early stages of development, but hold promise for the
future treatment of muscular dystrophy. Clinical trials and further research are needed to determine
the safety and efficacy of these therapies
Skeletal System
 The skeletal system of human beings refers to the framework of bones, joints, and
connective tissues that provide structure, support, and protection to the body.
 The key components and functions of the skeletal system are:
 Bones: The human body consists of 206 bones that vary in size and shape. Bones are
composed of hard and dense connective tissue that provides strength and support. They
serve as the anchor points for muscles, protect internal organs, and store minerals like
calcium and phosphorus.
 Cartilage: Cartilage is a flexible connective tissue found in certain joints and structures
such as the ears and nose. It acts as a cushion between bones, reducing friction and
absorbing shock.
 Ligaments: Ligaments are tough bands of fibrous tissue that connect bones to other bones
in joints, providing stability and preventing excessive movement.
 Axial Skeleton: The axial skeleton forms the central axis of the body and includes the
skull, vertebral column, and ribcage. The skull protects the brain, and the vertebral
 column (spine) supports the body's weight and houses the spinal cord. The ribcage
encloses and protects the heart, lungs, and other thoracic organs.
 Appendicular Skeleton: The appendicular skeleton comprises the bones of the limbs and
the shoulder and pelvic girdles. The upper limbs (arms) consist of the humerus (upper
arm bone), radius and ulna (forearm bones), and the hand bones. The lower limbs (legs)
include the femur (thigh bone), tibia and fibula (lower leg bones), and the foot bones. The
shoulder and pelvic girdles attach the limbs to the axial skeleton.
 Joints: Joints are the points where bones meet and allow for movement. There are
different types of joints, including hinge joints (e.g., elbow and knee) that enable bending
and straightening, ball-and-socket joints (e.g., hip and shoulder) that allow for a wide
range of motion, and pivot joints (e.g., between the atlas and axis vertebrae) that allow
rotational movement.

Skeletal System as Scaffold

 The skeletal system can be used as a scaffold for tissue growth in certain applications.
Scaffold-based tissue engineering is a field that aims to create artificial scaffolds to
support the growth and regeneration of tissues and organs.
 In some cases, the natural structure of the skeletal system can serve as a scaffold or
template for tissue engineering purposes.
 For example, bone tissue engineering often involves the use of scaffolds to facilitate the
repair and regeneration of bone defects or injuries. Synthetic or natural biomaterial
scaffolds, designed to mimic the properties of bone, can be used to fill the void left by a
bone defect.
 The scaffold provides a three-dimensional structure that supports the attachment,
proliferation, and differentiation of cells involved in bone regeneration. Over time, the
scaffold can be replaced by newly formed bone tissue, resulting in the restoration of bone
structure and function. In addition to bone tissue engineering, the skeletal system has also
been explored as a scaffold for other tissues. For instance, researchers have investigated
using decellularized bone or cartilage scaffolds as templates for the regeneration of other
tissues like muscle, blood vessels, or nerves.
 The existing extracellular matrix and structure of the skeletal system can provide a
framework for cells to populate and guide tissue growth. However, it's important to note
that using the skeletal system as a scaffold for tissue growth requires careful
consideration and modification to match the specific requirements of the target tissue.
 Additional steps, such as surface modifications, incorporation of bioactive molecules, or
cell seeding, may be necessary to optimize the scaffold's effectiveness for promoting
tissue regeneration.
Osteoporosis
Osteoporosis is a condition that weakens the bones and makes them more likely to break
(fracture), especially the bones in the hip, spine, and wrist. It occurs when the body loses bone
mass and density more quickly than it can be replaced, leading to fragile bones that are prone to
fracture.
Osteoporosis is a common condition, especially among older women, and it can increase
the risk of falls and fractures, which can result in significant pain and disability. Risk factors for
osteoporosis include being female, older age, having a family history of the condition, smoking,
drinking excessive amounts of alcohol, being thin or having a small body frame, and having a low
calcium intake. Treatment for osteoporosis aims to slow down bone loss, prevent fractures, and
treat fractures if they occur. Some of the treatments include:
Medications:
 Bisphosphonates, denosumab, and teriparatide are some of the medications that can slow
down bone loss and reduce the risk of fractures.
 Calcium and Vitamin D supplementation: Calcium and Vitamin D are essential for
healthy bones, and taking supplements can help maintain bone mass.
 Exercise: Weight-bearing and resistance exercises can help improve bone density and
reduce the risk of fractures.
 Lifestyle changes: Quitting smoking, reducing alcohol consumption, and eating a healthy
diet that includes enough calcium and Vitamin D can help maintain healthy bones. It's
important to work closely with a healthcare provider to develop a comprehensive
treatment plan for osteoporosis, as the right approach may vary depending on the
individual's specific needs and medical history.

Bioengineering solutions for osteoporosis

Bioengineering solutions for osteoporosis aim to improve bone health and prevent
fractures. Some of the approaches being explored include:
 Tissue engineering: This involves using scaffolds and growth factors to stimulate the
growth of new bone tissue and promote the repair of damaged bones. The goal is to
 create functional bone tissue that can replace the lost bone mass and density in
individuals with osteoporosis.
 Stem cell therapy: This involves using stem cells to replace the damaged bone cells and
promote the repair and regeneration of bone tissue. Stem cells can be taken from the
patient's own body (autologous stem cells) or from a donor (allogenic stem cells).
 Biomaterials: This involves using synthetic or natural materials to replace or augment
damaged bone tissue. Biomaterials can be designed to mimic the properties of natural
bone and promote the growth of new bone tissue.
 Gene therapy: This involves delivering a functional copy of a gene involved in bone
growth and repair to the affected bone cells. The goal is to restore the production of the
missing protein and improve bone health. These approaches are still in the early stages of
development, but hold promise for the future treatment of osteoporosis. Clinical trials and
further research are needed to determine the safety and efficacy of these therapies.
In addition, traditional treatments for osteoporosis, such as medication, exercise, and
lifestyle changes, will likely continue to play an important role in preventing fractures and
maintaining healthy bones in individuals with osteoporosis.